Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Korro Bio's Return on Capital Employed [ROCE] came in at -68.47% for Q2 2026, down 11.88 percentage points from -56.59% a year earlier but up 19.19 percentage points from the prior quarter.

Analysis

Korro Bio (KRRO) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Korro Bio's Return on Capital Employed [ROCE] was -77.15%, down 33.18 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -64.48 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -43.98% in FY2024 (+21.95 pp), -65.93% in FY2023 (-17.11 pp), -48.82% in FY2022 (-9.48 pp) and -39.34% in FY2021 (-26.66 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -97.33% (Q3 2023) to -36.34% (Q3 2021).
  • Year-over-year, Return on Capital Employed [ROCE] has declined for six consecutive quarters, with an average year-over-year change of -6.99 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2024 (a gain of 56.23 percentage points), and the weakest in Q4 2025 (a drop of 55.23 percentage points).
  • Business Quant data shows KRRO's Return on Capital Employed [ROCE] at -87.66% (Q1 2026), -97.03% (Q4 2025) and -60.44% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Korro Bio 281.05 Mn -128.11 Mn - -77.66%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -77.66%
Jun 30, 2026 -68.47%
Mar 31, 2026 -87.66%
Dec 31, 2025 -97.03%
Sep 30, 2025 -60.44%
Jun 30, 2025 -56.59%
Mar 31, 2025 -47.42%
Dec 31, 2024 -41.79%
Sep 30, 2024 -41.11%
Jun 30, 2024 -43.33%
Mar 31, 2024 -43.22%
Dec 31, 2023 -73.81%
Sep 30, 2023 -97.33%
Jun 30, 2023 -64.50%
Mar 31, 2023 -85.12%
Dec 31, 2022 -61.34%
Sep 30, 2022 -70.15%
Jun 30, 2022 -64.67%
Mar 31, 2022 -53.44%
Dec 31, 2021 -46.08%
API Access

Korro Bio Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KRRO&period=max&api_key=YOUR_API_KEY